New Accord to Improve Health and Vaccine Equity for 1.2 Billion People in Lower-Income Countries

Published
25 May 2022
2022
Share
  • Groundbreaking initiative will offer patented medicines and vaccines at lower cost to poorer nations
  • Rwanda, Ghana, Malawi, Senegal and Uganda are the first five countries to commit to join
  • Health officials in these countries will help identify and resolve hurdles beyond supply to inform the roll out in all 45 countries
  • Long-term goal is to close the health equity gap and help create a healthier world for 1.2 billion people·
  • For more information about the World Economic Forum Annual Meeting 2022, visit www.wef.ch/wef22

Davos-Klosters, Switzerland, 25 May 2022 A groundbreaking initiative launched today at the World Economic Forum Annual Meeting in Davos 2022 aims to greatly reduce the health inequities that exist between many lower-income countries and the rest of the world.

An Accord for a Healthier World is led by Pfizer. The pharmaceutical company will offer all its patent-protected medicines and vaccines, including the COVID jab, that are available in the United States and the European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries.

“As we learned in the global COVID-19 vaccine rollout, supply is only the first step to helping patients. We will work closely with global health leaders to make improvements in diagnosis, education, infrastructure, storage and more. Only when all the obstacles are overcome can we end healthcare inequities and deliver for all patients,” said Albert Bourla, Chairman and CEO of Pfizer.

Pfizer will work with healthcare officials in Rwanda, Ghana, Malawi, Senegal and Uganda to identify early insights and opportunities to ensure all medicines and vaccines can reach those in need. This will include expertise to support diagnosis, healthcare professional education and training along with supply chain management and other infrastructure enhancements. Learnings from these five countries will be applied to support a rollout to 40 more countries.

“This is how all global problems should be tackled,” said Lazarus Chakwera, President of Malawi. "The great thing about this accord is that it helps low-income countries without violating their dignity and agency as people, for it is a true partnership that involves both Pfizer and countries like Malawi sharing the burden of costs and tasks in the production and delivery of supplies that will save millions of lives.”

The collaboration seeks to identify quick and efficient regulatory pathways and procurement processes to reduce the longer amount of time it can take to make new medicines and vaccines available in these countries. Pfizer has committed to provide 23 medicines and vaccines that treat infectious diseases, certain cancers and rare and inflammatory diseases. It also plans to add future medicines and vaccines on a not-for-profit basis.

The accord, with funding from the Bill & Melinda Gates Foundation, is advancing work on the development of vaccine candidates for the prevention of Group B Streptococcus, a leading cause of stillbirth and newborn mortality in low-income countries. They are also discussing opportunities to support respiratory syncytial virus vaccine development, another maternal vaccine.

“Everyone, no matter where they live, should have the same access to innovative, life-saving drugs and vaccines,” said Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation. “[The accord] could help millions more people in low-income countries get the tools they need to live a healthy life. Pfizer is setting an example for other companies to follow.”

Paul Kagame, President of Rwanda, described the accord as an important step towards sustainable health security for countries at every income level. "Rapid and affordable access to the most advanced medicines and vaccines is the cornerstone of global health equity,” he said.

President Nana Addo Dankwa Akufo-Addo of Ghana, said true health equity needs strong cooperation between the public and private sectors. "We must continue to strive for quality healthcare for all people to live longer, stronger and healthier lives," he said.

Macky Sall, President of Senegal, said the accord works towards a better world. “Senegal proudly supports the launch of An Accord for a Healthier World to improve health equity and outcomes for the people of our country and across the world,” he said.

Yoweri Museveni, President of Uganda, said it is important that partners find new ways to address challenges in access to medicines. "It is the time to close the health equity gap," he said.

About the Annual Meeting 2022

For over 50 years, the World Economic Forum has been the international organization for public-private cooperation. The Annual Meeting is the focal point for leaders to accelerate the partnerships needed to tackle global challenges and shape a more sustainable and inclusive future. Convening under the theme History at a Turning Point: Government Policies and Business Strategies, the Annual Meeting 2022 and its 450 sessions brings together global leaders from business, government and civil society. Learn more about the programme and view sessions live and on-demand.

Notes to editors:

Learn about the Forum’s impact on http://wef.ch/impact

Watch live webcasts of sessions and get more information about the meeting at www.wef.ch/wef22

Guide to how to follow and embed sessions on your website at www.wef.ch/howtofollow

View the best photos from the event at https://www.flickr.com/photos/worldeconomicforum/

Read the Forum Agenda at http://wef.ch/agenda

Read the Forum Agenda in Spanish, Japanese and Mandarin

Become a fan of the Forum on Facebook at http://wef.ch/facebook

Watch Forum videos at http://wef.ch/youtube

Listen to the Forum’s podcasts at wef.ch/podcasts

Follow the Forum on Twitter via @wef and @davos, and join the conversation using #wef22

Follow the Forum on Instagram at http://wef.ch/instagram

Follow the Forum on LinkedIn at http://wef.ch/linkedin

Subscribe to Forum news releases at http://wef.ch/news

All opinions expressed are those of the author. The World Economic Forum Blog is an independent and neutral platform dedicated to generating debate around the key topics that shape global, regional and industry agendas.
About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum